Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11834490 CD112 variant immunomodulatory proteins and uses thereof

Patent 11834490 was granted and assigned to ALPINE IMMUNE SCIENCES, INC. on December, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 7 Dec, 2023
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 7 Dec, 2023
Edits made to:
Infobox (+62 properties)
Article (+318 characters)
‌

 US Patent 11834490 CD112 variant immunomodulatory proteins and uses thereof

Article

Patent abstract

Provided herein are immunomodulatory proteins comprising variant CD112 and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.

Infobox
Is a
Patent
Patent
0
Patent Applicant
‌
ALPINE IMMUNE SCIENCES, INC.
0
Current Assignee
‌
ALPINE IMMUNE SCIENCES, INC.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
118344900
Patent Inventor Names
Dan Ardourel0
Daniel William Demonte0
Joseph L. Kuijper0
Mark F. Maurer0
Michael Kornacker0
Ryan Swanson0
Date of Patent
December 5, 2023
0
Patent Application Number
163210000
Date Filed
July 27, 2017
0
Patent Citations
‌
US Patent 11117948 CD80 variant immunomodulatory proteins and uses thereof
0
‌
US Patent 11117949 CD80 variant immunomodulatory proteins and uses thereof
0
‌
US Patent 11117950 CD80 variant immunomodulatory proteins and uses thereof
0
‌
US Patent 11096988 CD80 variant immunomodulatory proteins and uses thereof
0
‌
US Patent 11078282 CD80 variant immunomodulatory proteins and uses thereof
0
‌
US Patent 7094875 Co-stimulatory polypeptides
0
‌
US Patent 7125717 Metabolically activated recombinant viral vectors and methods for their preparation and use
0
‌
US Patent 7153510 Recombinant vesiculoviruses and their uses
0
‌
US Patent 7172893 Virus vectors and methods of making and administering the same
0
‌
US Patent 7238526 Methods and cell line useful for production of recombinant adeno-associated viruses
0
‌
US Patent 7241447 Adeno-associated virus vectors and uses thereof
0
‌
US Patent 7247615 Peptide agonists of prostate-specific antigen and uses therefor
0
‌
US Patent 7332581 Polypeptide variants with altered effector function
0
‌
US Patent 7368116 Method of enhancing a targeted immune response against tumors
0
‌
US Patent 7371826 Polypeptide variants with altered effector function
0
‌
US Patent 7378087 Method of enhancing an immune response
0
‌
US Patent 7537924 Virus strains
0
‌
US Patent 7550296 Generation of replication competent viruses for therapeutic use
0
‌
US Patent 7588767 Microorganisms for therapy
0
‌
US Patent 7588771 Microorganisms for therapy
0
‌
US Patent 7662398 Microorganisms for therapy
0
‌
US Patent 7662627 Adeno-associated virus materials and methods
0
‌
US Patent 7731952 Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response
0
‌
US Patent 7731974 Mutant vesicular stomatitis viruses and uses thereof
0
‌
US Patent 7754221 Microorganisms for therapy
0
‌
US Patent 7811814 Tetracycline-regulated adeno-associated viral (AAV) vectors for gene delivery to the nervous system
0
‌
US Patent 7897146 Treatment using herpes simplex virus
0
‌
US Patent 7906111 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
0
‌
US Patent 7927585 Production of recombinant AAV virions
0
‌
US Patent 7943374 Super-size adeno-associated viral vector harboring a recombinant genome larger than 5.7 kb
0
‌
US Patent 7968340 Structural protein of adeno-associated virus with modified antigenicity, its production and its use
0
‌
US Patent 8007780 AAV vectors for gene delivery to the lung
0
‌
US Patent 8445447 B7-DC variants immunogenic compositions and methods of use thereof
0
‌
US Patent 8911726 Stabilized human Igg4 antibodies
0
‌
US Patent 8956619 Soluble CD80 as a therapeutic to reverse immune supression in cancer patients
0
‌
US Patent 9103831 Orally administered bacteria as vehicles for systemic delivery of agents
0
‌
US Patent 9327014 Immunotherapy with binding agents
0
‌
US Patent 9453227 Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
0
‌
US Patent 11230588 CD80 variant immunomodulatory proteins and uses thereof
0
‌
US Patent 11319359 Immunomodulatory proteins with tunable affinities
0
‌
US Patent 6855317 Immunological herpes simplex virus antigens and methods for use thereof
0
‌
US Patent 6887471 Method to inhibit T cell interactions with soluble B7
0
‌
US Patent 6897045 Adeno-associated virus vectors
0
‌
US Patent 6936257 Recombinant Venezuelan equine encephalitis virus vaccine
0
‌
US Patent 6998252 Recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences
0
‌
US Patent 7001765 Adeno-associated virus vector for boosting immunogenicity of cells
0
‌
US Patent 7033826 Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenoviruses
0
Patent Primary Examiner
‌
Michael D Burkhart
0

Find more entities like US Patent 11834490 CD112 variant immunomodulatory proteins and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.